Perindopril Erbumine description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Perindopril Erbumine

Aurobindo Pharma Limited


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION


Perindopril Erbumine Tablets

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 2 mg Bulk Tablet Label


12000 Tablets











BULK SHIPMENT

PLEASE HANDLE CAREFULLY

Rx only


Perindopril Erbumine Tablets 2 mg


Each tablet contains:


CAUTION:


Store at




Aurobindo Pharma Limited


Perindopril Erbumine

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg Bulk Tablet Label



10000 Tablets











BULK SHIPMENT
PLEASE HANDLE CAREFULLY

Rx only

Perindopril Erbumine Tablets 4 mg

Each tablet contains:

CAUTION:

Store at



Aurobindo Pharma Limited


Perindopril Erbumine

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 8 mg Bulk Tablet Label


5000 Tablets











BULK SHIPMENT

PLEASE HANDLE CAREFULLY

Rx only


Perindopril Erbumine Tablets 8 mg


Each tablet contains:


CAUTION:


Store at




Aurobindo Pharma Limited


Perindopril Erbumine

Perindopril Erbumine

Perindopril Erbumine TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:65862-286
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
PERINDOPRIL ERBUMINE PERINDOPRILAT 2 mg

Inactive Ingredients

Ingredient Name Strength
ANHYDROUS LACTOSE
SILICON DIOXIDE
cellulose, microcrystalline
MAGNESIUM STEARATE

Product Characteristics

Color Size Imprint Code Shape
WHITE (White to Off-white) 5 mm D;5;7 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:65862-286-53 12000 in 1 BAG

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA079070 2009-11-10


Perindopril Erbumine

Perindopril Erbumine TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:65862-287
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
PERINDOPRIL ERBUMINE PERINDOPRILAT 4 mg

Inactive Ingredients

Ingredient Name Strength
ANHYDROUS LACTOSE
SILICON DIOXIDE
cellulose, microcrystalline
MAGNESIUM STEARATE

Product Characteristics

Color Size Imprint Code Shape
WHITE (White to Off-white) 8 mm D;5;8 CAPSULE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:65862-287-19 10000 in 1 BAG

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA079070 2009-11-10


Perindopril Erbumine

Perindopril Erbumine TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:65862-288
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
PERINDOPRIL ERBUMINE PERINDOPRILAT 8 mg

Inactive Ingredients

Ingredient Name Strength
ANHYDROUS LACTOSE
SILICON DIOXIDE
cellulose, microcrystalline
MAGNESIUM STEARATE

Product Characteristics

Color Size Imprint Code Shape
WHITE (White to Off-white) 8 mm D;5;9 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:65862-288-59 5000 in 1 BAG

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA079070 2009-11-10


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.